chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Flu like symptoms; I can't go for a walk; extremely ill; Iam in Pain; it hurt so much, I cried; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old female patient received BNT162b2 (BNT162B2), on 18Apr2022 as dose 2, single (Lot number: FJ6369) at the age of 43 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Depression" (unspecified if ongoing); "Anxiety" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: BNT162b2 (Dose 1, Lot No.- FJ6369), administration date: 28Mar2022, when the patient was 43-year-old, for Covid-19 Immunization. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset Apr2022, outcome "unknown", described as "Flu like symptoms"; GAIT DISTURBANCE (non-serious) with onset Apr2022, outcome "unknown", described as "I can't go for a walk"; PAIN (non-serious) with onset Apr2022, outcome "unknown", described as "Iam in Pain"; ILLNESS (non-serious) with onset Apr2022, outcome "unknown", described as "extremely ill"; CRYING (non-serious) with onset Apr2022, outcome "unknown", described as "it hurt so much, I cried". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of influenza like illness, gait disturbance, illness, pain.  Additional information: Consumer stated, "Patient had a Additional information: Consumer stated, "Patient had a complaint about the Pfizer shot, it made me extremely sick. he got it 2 days ago, he got it on Monday, and having bad reactions to it, later Flu like symptoms, he can't go for a walk, and missing him classes." When paraphrased the concern: Consumer stated, "Yes, extremely ill." both of them? The first one was administered on 28Mar2022, FJ6369 and the second one was administered on 18Apr2022" Other medical condition: Consumer stated, " 'Spider bite'(not clarified further hence not captured in tab), felt this way the first time got the shot and the same time, first time tonight I got severe flu like symptom, it hurt so much,  cried." Lab test: Consumer stated, "he had a mammogram and a Blood test." Result: Consumer stated, " don't know the result, he had to get another test, the tissue is too thin" Treatment for adverse events: Consumer stated, "Ibuprofen but he missed 2 of him classes, it doesn't work, Ibuprofen was temporarily." LOT# for Ibuprofen: Consumer stated, "oh man, he don't know the lot number, he can't do that." Consumer hung up the call abruptly. Thus, further probing could not be done. Hence, limited information available over the call. Description of Product Complaint: Consumer stated, "I have a complaint about the Pfizer shot, it made me extremely sick. he got it 2 days ago, he got it on Monday,  having bad reactions to it, later Flu like symptoms, he cant go for a walk,  and missing him classes." Name of the vaccine: Pfizer COVID-19 vaccine. Consumer hung up the call abruptly. Thus, further probing could not be done. Hence, limited information available over the call.
Tingling of mouth, sweating, dizziness. BP 134/86 (pulse 85), 98% O2 sat. Given juice. Final BP 128/82.
COVID 19  Severe rash on upper left arm starting 14 days after vaccine administration. very mildly itchy
Med error vaccine was not diluted prior to use, patient received higher dose. Patient was fine after immunization, mom was informed, Patient had fever the following days. MD was notified, and recommended motrin and acetaminophen and rest. Patient was fine after 2 days mom confirmed.
Patient has not reported signs/symptoms of adverse effects; PROQUAD was administered after the not supported TE.; This spontaneous report was received from a medical assistant referring to a patient of unspecified age and gender. Information regarding the patient's medical history, concurrent conditions, concomitant therapies and previous drug reactions or allergies was not provided.   On 17-JUL-2023, the patient was administered an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) (dose, route of administration and anatomical site of vaccination were not reported; lot number W038812 has been verified to be valid, expiration date reported and established as 04-JUN-2024) as prophylaxis.  The vaccine was exposed to a temperature exposure of 11 degrees Celsius during a time frame of 120 hours. There was no previous temperature excursion (product storage error), and no data logger was involved. No adverse event was reported (no adverse event).  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2308USA003217: US-009507513-2308USA003164: US-009507513-2308USA003164:
felt like something was wrong with bone  in the arm/it felt bad to have that feeling; had pain in arm where he received the shot; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (felt like something was wrong with bone  in the arm/it felt bad to have that feeling) and PAIN IN EXTREMITY (had pain in arm where he received the shot) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 067F21A, 044A21A and 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included ENALAPRIL for Blood pressure management.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 15-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. In December 2021, the patient experienced FEELING ABNORMAL (felt like something was wrong with bone  in the arm/it felt bad to have that feeling) and PAIN IN EXTREMITY (had pain in arm where he received the shot). At the time of the report, FEELING ABNORMAL (felt like something was wrong with bone  in the arm/it felt bad to have that feeling) and PAIN IN EXTREMITY (had pain in arm where he received the shot) had resolved.            Patient said it was tough for him to exercise due to this symptom. Patient reported that  occasionally he experienced a sensation in his arm, but it was not painful and had gotten much better. He says that the symptom eventually went away. No treatment medications was provided by the reporter.
Dizziness, nausea, palpitation, fatigue, tired, and pain on the side of my heart
I was 5 weeks pregnant when I received this vaccine. I noticed a painful lump in my left inner thigh two days later. I miscarried at 7 weeks pregnant on 10/20/17.
Patient had dizziness. Given apple juice, water. Dizziness resolved, stable, released from vaccination site.
Site: Pain at Injection Site-Mild, Additional Details: Pt received vaccine at 4:02 pm, started to feel faint at 405 pm( became pale and diaphoretic per). Called for NP help from in next room. Provided pt with ice packs. BP 100/62. Provided coca cola after patient stated he had not eaten since morning. Patient started to get color in face. BP re-check at 4:22 pm was 110/80. Pt was able to ambulate to waiting room at 4:35 pm. Pt & mom left waiting room feeling better at 5 :05pm
Patient claims that she has experienced a fever, headache, nausea/vomiting, and rash down her right arm near the injection site. Counseled patient to take Tylenol for the fever, benadryl  orally for the rash, and Emetrol for the nausea. Also advised the patient to get in touch with her physician and inform them of her reaction.
p/vax pt exp flu-like feeling; achiness in feet & back of hand; T101;
Patient requested FLUARIX Quad but FLUVIRIN was administered. No adverse effects were noted.
Information has been received from a consumer concerning her daughter a 19 year old female who on 04-OCT-2006 was vaccinated with the first dose of GARDASIL. In December 2006, the patient was vaccinated with a second dose of GARDASIL. In April 2007, she was vaccinated with a third dose of GARDASIL. Concomitant therapy included hormonal contraceptives (unspecified). The patient received an abnormal pap smear. The abnormal cells were diagnosed as HPV. The patient sought unspecified medical attention. At the time of reporting the patient had not recovered from HPV. The patient's physician plans to retest in 3 months. Additional information has been requested.
supposed to get the TUBERSOL test but instead got IPOL with no AE; 60 year old patient received IPOL/no AE; Initial information received on 28-Apr-2021 regarding an unsolicited valid non-serious case from a other health professional.  This case is linked to cases 2021SA148354 and 2021SA149533 (same reporter).  This case involves a 60-year-old male patient who received intradermal 0.1 ml dose of IPV (VERO) [IPOL] (in the left forearm, lot R1F801M, expiry date-28-Sep-2021) by mistake instead of TUBERCULIN TEST [TUBERSOL] for tuberculin test on 19-Apr-2021 (product administered to patient of inappropriate age) and (wrong product administered).  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  It was a case of actual medication error due to wrong vaccine administered and inappropriate age at vaccine administration (latency same day).  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
I woke up to grab a snack. I noticed a neck spasm of the left side of my body. It is extremely painful and incredibly tight. No other info at this time. I took a muscle relaxer prescribed for MVA trauma to see if that helps (Robaxin).
swelling,//left arm, around the site of injection; darkened, oval ring around the site of injection; pain at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th June 2021, the patient received the 1st dose of Shingrix. On 29th June 2021, immediately after receiving Shingrix, the patient experienced injection site pain. On 30th June 2021, the patient experienced injection site coloration. On an unknown date, the patient experienced injection site swelling. On an unknown date, the outcome of the injection site pain and injection site coloration were not recovered/not resolved and the outcome of the injection site swelling was recovering/resolving.   It was unknown if the reporter considered the injection site pain, injection site swelling and injection site coloration to be related to Shingrix.  Additional details were provided as follows: This case was reported by patient herself. The pain at injection site begin immediately and reoccurs whenever she have to lift or carry something heavy, such as groceries. The swelling began a few days after receiving the injection and was still present. The oval ring around the site of injection appeared a day or so after the injection. The oval ring appeared to be approximately two to two and half inches wide and was still present. The patient received 1st dose of Shingrix and experienced pain, swelling and oval ring. Till the time of reporting the patient did not receive 2nd dose. The reporter did not consent to follow up.
After receiving Tdap 3-27-07 for knee abrasion that occurred 2d. prior, pt. developed red, swollen induration at injection site which became sensitive and painful resulting in muscle spasm and tingling. Also had concomitant Id. Hx fever to 105 w/viral URI.
On 28AUG91 mom called the clinic to report pt was seen by MD for "abscess due to MMR inject given on 26AUG91; no fever on 28AUG91,  but some redness & discomfort around inject site;
Patient received covid shot, after a few hours the arm began to swell and itch.  The patient went to an urgent care and was told that was a normal reaction to the shot. The arm continued to swell and itch and began to bruise.  The bruise has lasted the entire month but has faded significantly.  Primary care physician told patient the shot may have been given too low and to ask the pharmacist to give the booster 3 finger width below the shoulder.
Shortly after receiving vaccines- pt walked to front of office and fainted-landing directly on face.  He briefly lost consciousness, and had clonic tonic posturing according to dad. This lasted a few seconds and then he was awake and alert.  He had bleeding from nose and mouth. He was able to walk back to exam room. HR 99  Pulse ox 97%. Ice packs were applied to nose and mouth. PE: alert and oreinted x 3. Nose- fresh blood in both nares and swelling of nasal bridge -tender to palp. Abrasion on nose and under left nares. Mouth- 4 upper incisors with swelling and bleeding around gums and appear displaced. Laceration with oozing on lower lip.. Pt was monitored for 40 minutes.  Dad also felt lightheaded and we had him lay down and drink water. Bleeding and oozing stopped.  Pt was able to walk. Denies headache, dizziness, nausea or double vision. Denies head injury. Plan- pt will go to ED for further eval and will likely need a dentist. Dad was instructed to take pt to ED immediately for further EVAL. On discharge --90/56  HR 72.
Patient had a syncope episode and hit head on floor causing laceration of chin requiring 4 sutures and follow up head CT (normal results).
Area of injection site on my arm is swollen, red and irritated 3 inches in diameter.  I?ve never had a reaction to any flu shot, and get them every year.
Red and warm/covid arm at the injection site; Slightly itchy; Inflamed lymph nodes on arm pit; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red and warm), PRURITUS (Slightly itchy) and LYMPHADENOPATHY (Inflamed lymph nodes on arm pit) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 19B29A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Red and warm), PRURITUS (Slightly itchy) and LYMPHADENOPATHY (Inflamed lymph nodes on arm pit). At the time of the report, ERYTHEMA (Red and warm), PRURITUS (Slightly itchy) and LYMPHADENOPATHY (Inflamed lymph nodes on arm pit) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment details were provided.
11MAY91 onset couldn't breathe - hx of asthma taken to ER; 12MAY91 started vomiting, trouble breathing lips cyanotic returned to Hosp admited til 14AUG91, placed on 02 had fever fr 8MAY91-17MAY91 102-103;
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. Patient had drug reaction/allergy to codeine. Approximately on an unknown date in 2014 (also reported as recently), the patient was vaccinated with ZOSTAVAX  vial (lot # unknown, expiry date unknown), subcutaneous. Concomitant medications were unspecified. Approximately on an unknown date in 2014, pharmacist reported that the patient called and stated that she had a red area by the injection site. Pharmacist stated that she informed the patient that this was most likely an injection site reaction. There was no PQC. The outcome of injection site reaction was reported as not recovered/not resolved. Causality of the reported event was unknown. Additional information has been requested.
Information has been received from a registered nurse concerning a 6 month old patient with an unknown medical history who on 01-NOV-2007 was vaccinated with a pre-measured vial of PNEUMOVAX 23 intramuscularly in the upper thigh.  The patient received PNEUMOVAX 23 instead of PREVNAR.  This was not product confusion, this was a medical error.  The patient did not experience any known symptoms.  Concomitant therapy included PEDVAXHIB (MSD) (Lot #655397/0073U) and PEDIARIX (Lot #AC.  Additional information has been requested.
the patient had generalized joint pain on 9/26/2018; Information has been received from a nurse prescriber referring to a 49-year-old female patient. The patient's pertinent medical history included asthma. The concomitant medications included unknown asthma medication. The drug reactions or allergies were not reported.  On 25-SEP-2018, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot #: N032750, expiration date: 20-NOV-2019, dose, frequency and route were not reported) for prophylaxis (reported as "immigration medical exam").         On 26-SEP-2018, the patient had generalized joint pain and went to an unspecified emergency room.The patient "received an unspecified pain shot". On the same date, the patient went home from the unspecified Emergency Room. The patient had unspecified steroid treatment on unspecified dates and had continued generalized joint pain. Information about lab diagnostics/studies was not provided. The patient did seek medical attention. The causality assessment was not provided.
Information has been received from a certified medical assistant referring to unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored VARIVAX (Merck) (lot #, strength, dosage, route unspecified). No adverse effects were reported. Additional information is not expected because the physician did not want to be contacted.
severe right arm injection site pain; This spontaneous report as received from a pharmacist refers to a 82-year-old female patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. Historical vaccine included pneumococcal 13v conj vaccine (CRM197) (PREVNAR 13) (administered last year).  On 04-DEC-2019, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) intramuscularly in the right deltoid, lot # S018405, expiration date 28-MAR-2021 (exact dose was not reported) for prophylaxis(reported also as because she received PREVNAR 13 last year). On the same date, the patient experienced severe right arm injection site pain and she could not touch her arm. The patient was taking acetaminophen (TYLENOL) every four hours. She did not sought medical attention.  The outcome of injection site pain was not recovered at the reporting time. The causality assessment between the event and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) was not reported.
This is a spontaneous report from a contactable consumer, the patient. A 63-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ET1685) via intramuscular route of administration in the left arm on 21Dec2020 at 15:30 (at the age of 63-years-old) as a single dose for COVID-19 immunization. The patient had no medical history. Relevant family medical history was reported as not applicable. Concomitant medications were not reported. On an unspecified date, the patient experienced left arm pain. The clinical outcome of left arm pain was unknown.
That night, after the first shot, I woke up from the pain.; Ever since then my periods have been irregular and painful, last longer and are heavier.; Ever since then my periods have been irregular and painful, last longer and are heavier.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 17Apr2021 10:45 (Batch/Lot number: unknown) at the age of 35 years as dose 1, single and administered in arm right, administration date 08May2021 10:30 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: BUPROPION; SPIRONOLACTONE. The following information was reported: HEAVY MENSTRUAL BLEEDING (non-serious) with onset 17Apr2021 23:45, outcome "not recovered", described as "That night, after the first shot, I woke up from the pain."; MENSTRUAL DISCOMFORT (non-serious), HEAVY MENSTRUAL BLEEDING (non-serious) all with onset 17Apr2021 23:45, outcome "not recovered" and all described as "Ever since then my periods have been irregular and painful, last longer and are heavier.". Therapeutic measures were taken as a result of heavy menstrual bleeding, menstrual discomfort, heavy menstrual bleeding.  Additional information: The patient did not have any known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  The facility where the most recent COVID-19 vaccine was administered was Hospital.   This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
pt transferred from home to ER via amb d/t fever, shaking & chills;pt was irritable, t104.2 R;P160, R72 crying;heart tachy;poss convuls;
I became severely nauseated; had a bad headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 10Apr2021 09:45 (Lot number: EW0161) at the age of 31 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "covid prior vaccination: Yes" (unspecified if ongoing), notes: if covid prior vaccination: Yes; "Asthma" (unspecified if ongoing); "hypoglycemia" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing); "IBS" (unspecified if ongoing); "endometriosis" (unspecified if ongoing); "known allergy: extensive allergies" (unspecified if ongoing); "known allergy: fruits" (unspecified if ongoing); "known allergy: nature" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE. Past drug history included: Nsaids, reaction(s): "known allergies: NSAIDs". The following information was reported: NAUSEA (non-serious) with onset 01May2021 22:00, outcome "not recovered", described as "I became severely nauseated"; HEADACHE (non-serious) with onset 01May2021 22:00, outcome "not recovered", described as "had a bad headache". Therapeutic measures were not taken as a result of nausea, headache.  Additional Information: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was diagnosed with COVID-19. Since the vaccination, patient has been not tested for COVID-19. Minutes after dose 1 patient became severely nauseated and had a bad headache. Patient was put on watch for an hour before being released.   No follow-up attempts are possible. No further information is expected.